Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Oncology Institute Inc | TOI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.09 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.33 - 2.655 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 1.09 | USD |
Oncology Institute Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
809.76M | 73.75M | - | 324.24M | -83.07M | -1.13 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Oncology Institute News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TOI Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.13 | 1.29 | 1.07 | 1.14 | 76,141 | -0.04 | -3.54% |
1 Month | 1.5329 | 1.63 | 1.07 | 1.31 | 87,355 | -0.4429 | -28.89% |
3 Months | 2.16 | 2.18 | 1.07 | 1.60 | 113,589 | -1.07 | -49.54% |
6 Months | 2.07 | 2.655 | 1.07 | 1.82 | 214,015 | -0.98 | -47.34% |
1 Year | 0.4973 | 2.655 | 0.33 | 1.03 | 378,164 | 0.5927 | 119.18% |
3 Years | 9.86 | 12.66 | 0.33 | 2.14 | 239,507 | -8.77 | -88.95% |
5 Years | 9.86 | 12.66 | 0.33 | 2.14 | 239,507 | -8.77 | -88.95% |
Oncology Institute Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. |